Ma, V. T., Forati, A. W., Zhou, A. Y., McCracken, T., Hosny, M., Steimle, A. K., Rahimi, G., Patel, J. D., Burkey, C., Caraway, J., Wood, A., Harris, M. S., Birbrair, A., Sahasrabudhe, D. M., Hollnagel, F., Doolittle, G. C., Mathew, N. S., In, G. K., Victor, A. I. (2026). Optimal timing of circulating tumor DNA (ctDNA) dynamics to prognosticate immune checkpoint inhibitors (ICI) efficacy in patients with advanced stage melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9534